Old Web
English
Sign In
Acemap
>
Paper
>
Antitumor activity of ipilimumab after pembrolizumab in patients with advanced melanoma in KEYNOTE-006.
Antitumor activity of ipilimumab after pembrolizumab in patients with advanced melanoma in KEYNOTE-006.
2017
Georgina V. Long
C. Robert
Ana Arance
C. Blank
A. Ribas
Paul Lorigan
L. Mortier
Jacob Schachter
Mark R. Middleton
Bart Neyns
Mario Sznol
Honghong Zhou
Scot Ebbinghaus
Nageatte Ibrahim
Neil Steven
Keywords:
Immunology
Melanoma
Ipilimumab
Pembrolizumab
Medicine
in patient
antitumor activity
advanced melanoma
Oncology
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]